News | May 04, 2026
Moderna posts Q1 2026 loss despite revenue surge
Growth was supported by stronger COVID vaccine sales and expanded government supply agreements in international markets
Growth was supported by stronger COVID vaccine sales and expanded government supply agreements in international markets
Approval for generic Ozempic® in Canada strengthens OneSource’s global CDMO footprint in complex peptide injectable manufacturing
Workshop focused on strengthening sterile processing standards, infection prevention, and CSSD best practices in healthcare settings
Early implementation of West Synchrony S1 platform aims to accelerate biologics and vaccine development while reducing manufacturing risk for biopharma partners
Hospital project inaugurated by Devendra Fadnavis aims to strengthen healthcare access across North Maharashtra and nearby regions
The initiative pairs consumer engagement with a public health message about prevention and early detection
The company’s Growth Portfolio delivered $6.2 billion in revenue
Lifts full-year outlook as obesity drug boom accelerates
The renewal covers two versions of the IQOS device and three HEETS tobacco variants
Under the terms, Arcellx shareholders received $115 per share in cash plus a non-transferable contingent value right
Subscribe To Our Newsletter & Stay Updated
